ALLMedicine™ Adrenomyeloneuropathy Center
Research & Reviews 45 results
Annals of Neurology; Schäfer L, Roicke H et. al.
Jun 10th, 2021 - X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder characterized by progressive demyelination ranging from mild myelopathic forms (adrenomyeloneuropathy [AMN]) to severe cerebral variants (adult cerebral adrenoleukodystrophy [ACALD])...
Nature Communications; Weinhofer I, Rommer P et. al.
Mar 24th, 2021 - X-linked adrenoleukodystrophy (X-ALD), the most frequent monogenetic disorder of brain white matter, is highly variable, ranging from slowly progressive adrenomyeloneuropathy (AMN) to life-threatening inflammatory brain demyelination (CALD). In th...
NeuroImage. Clinical; Adanyeguh IM, Lou X et. al.
Jan 31st, 2021 - Progressive myelopathy causes severe handicap in men with adrenomyeloneuropathy (AMN), an X-linked disorder due to ABCD1 pathogenic variants. At present, treatments are symptomatic but disease-modifying therapies are under evaluation. Given the sm...
JAMA Neurology; Azar C, Shor N et. al.
Feb 25th, 2020 - Adrenomyeloneuropathy Masquerading as Chronic Myelitis.|2020|Azar C,Shor N,Nadjar Y,|
Paediatric Anaesthesia; Kloesel B, Dua N et. al.
Dec 17th, 2019 - X-linked adrenoleukodystrophy is a progressive demyelinating disease that primarily affects males with an incidence of 1:20 000-30 000. The disease has a wide spectrum of phenotypic expression and may include adrenal insufficiency, cerebral X-link...